These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 6140282

  • 1. H2-blockers: how safe and how effective?
    Spiro HM.
    J Clin Gastroenterol; 1983; 5 Suppl 1():143-7. PubMed ID: 6140282
    [Abstract] [Full Text] [Related]

  • 2. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
    Di Mario F, Gottardello L, Germanà B, Dotto P, Grassi SA, Vianello F, Battaglia G, Leandro G, Burra P, Salvagnini M.
    Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650
    [Abstract] [Full Text] [Related]

  • 3. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 4. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
    Freston JW.
    Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294
    [Abstract] [Full Text] [Related]

  • 5. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E.
    Wien Med Wochenschr; 1983 Dec; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract] [Full Text] [Related]

  • 6. Review of peptic ulcer maintenance trials.
    Robinson M.
    Am J Med; 1984 Nov 19; 77(5B):23-9. PubMed ID: 6095657
    [Abstract] [Full Text] [Related]

  • 7. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B, Müller P, Dammann HG.
    Wien Med Wochenschr; 1982 May 31; 132(10):223-8. PubMed ID: 6126962
    [Abstract] [Full Text] [Related]

  • 8. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].
    Hüttemann W.
    Fortschr Med; 1983 Jan 27; 101(4):139-41. PubMed ID: 6131857
    [Abstract] [Full Text] [Related]

  • 9. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
    Korman MG, Hansky J, Eaves ER, Schmidt GT.
    Gastroenterology; 1983 Oct 27; 85(4):871-4. PubMed ID: 6136450
    [Abstract] [Full Text] [Related]

  • 10. Ranitidine: a pilot study in Japan.
    Takemoto T, Okazaki Y, Okita K, Namiki M, Ishikawa M, Oshiba S, Kurokawa K.
    Scand J Gastroenterol Suppl; 1981 Jun 27; 69():125-8. PubMed ID: 6119776
    [Abstract] [Full Text] [Related]

  • 11. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 12. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
    Sevvel S, Ananthakrishnan N, Kate V.
    Trop Gastroenterol; 1996 Nov 11; 17(4):227-9. PubMed ID: 9094865
    [Abstract] [Full Text] [Related]

  • 13. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A, Barbara L, Bianchi-Porro G, Blasi A, Canelli B, Cheli R, Dal Monte R, Dammann HG, Francavilla A, Hentschel E.
    Z Gastroenterol; 1985 Dec 11; 23(12):665-9. PubMed ID: 2868581
    [Abstract] [Full Text] [Related]

  • 14. Medical treatment of peptic ulcer disease.
    Andersen BN.
    Acta Chir Scand Suppl; 1988 Dec 11; 547():88-92. PubMed ID: 2906493
    [Abstract] [Full Text] [Related]

  • 15. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM, Misiewicz G.
    Clin Gastroenterol; 1984 May 11; 13(2):501-41. PubMed ID: 6146417
    [No Abstract] [Full Text] [Related]

  • 16. Long term cimetidine therapy for the prevention of recurring peptic ulcer: a multicenter study.
    Rohner HG.
    Z Gastroenterol; 1985 Aug 11; 23(8):403-11. PubMed ID: 3933199
    [Abstract] [Full Text] [Related]

  • 17. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T, Lemaire M, Agostini H.
    Eur J Gastroenterol Hepatol; 1995 Jul 11; 7(7):661-5. PubMed ID: 8590162
    [Abstract] [Full Text] [Related]

  • 18. A double-blind endoscopically controlled trial of ranitidine in a high incidence area.
    Moshal MG, Spitaels JM, Khan F.
    Scand J Gastroenterol Suppl; 1981 Jun 11; 69():129-31. PubMed ID: 6119777
    [Abstract] [Full Text] [Related]

  • 19. Duodenal and gastric ulcer healing rates: a review.
    Legerton CW.
    Am J Med; 1984 Nov 19; 77(5B):2-7. PubMed ID: 6095656
    [Abstract] [Full Text] [Related]

  • 20. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT, Tkachenko EI, Grinevich VB, Sultanov VK, Inozemtsev SA.
    Ter Arkh; 1989 Nov 19; 61(8):59-62. PubMed ID: 2573963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.